compounded semaglutide news compounding fda FDA moves to stop compounding GLP-1 drugs versions of weight loss – FDA alerts health care providers,

Michelle's approach is rooted in comprehensive consultation, education, and true patient advocacy

Read the full article to see what a more sustainable approach looks like: Marsh McLennan Agency #ObesityCare #WeightManagement #WorkplaceWellbeing Why obesity care strategies must go beyond GLP1s to drive sustainable outcomes To view or add a comment, sign in A very special thanks to my friend Betsy Nota-Kirby for her partnership, and for dropping some of her vast knowledge on GLP-1 strategies within this HR Dive article

Rebalance: Establish sustainable habits like better sleep, stress management, and dietary consistency

The positive effect was particularly pronounced in trained individuals